Diamox and Hepatitis - a phase IV clinical study of FDA data

Summary:

Hepatitis is reported as a side effect among people who take Diamox (acetazolamide), especially for people who are female, 50-59 old, also take Lasix, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Hepatitis when taking Diamox. It is created by eHealthMe based on reports of 4,260 people who have side effects when taking Diamox from the FDA, and is updated regularly.

What is Diamox?

Diamox has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,711 Diamox users. Check the latest studies of Diamox.

What is Hepatitis?

Hepatitis (inflammation of the liver) is found to be associated with 1,463 drugs and 1,522 conditions by eHealthMe. Check the latest studies of Hepatitis.

On Jul, 16, 2026

4,260 people reported to have side effects when taking Diamox.
Among them, 18 people (0.42%) have Hepatitis.

Among these 18 people:

What is the gender of people who have Hepatitis when taking Diamox? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Hepatitis when taking Diamox? *

What are other drugs people take besides Diamox? *

What are other side effects people have besides Hepatitis? *

Fall: 15 people, 83.33%
Dizziness: 14 people, 77.78%
Urinary Tract Infection: 14 people, 77.78%
Gallstones (stone formation by bile component): 14 people, 77.78%
Dyspnea (difficult or laboured breathing): 14 people, 77.78%
Acute Kidney Failure: 14 people, 77.78%
Muscle Aches (muscle pain): 14 people, 77.78%
Gallbladder Disorder: 13 people, 72.22%
Exostosis (formation of new bone on the surface of a bone): 13 people, 72.22%
Faecaloma (hard mass of fecal matter): 13 people, 72.22%

What are the existing conditions these people have? *

Thyroid Diseases: 1 person, 5.56%
Metastases To Bone (cancer spreads to bone): 1 person, 5.56%
Irritable Bowel Syndrome: 1 person, 5.56%
Hepatitis C: 1 person, 5.56%
Headache (pain in head): 1 person, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 5.56%
Depression: 1 person, 5.56%
Acute Myocardial Infarction (acute heart attack): 1 person, 5.56%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Diamox and have Hepatitis?

- Check whether Hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diamox:

Diamox (4,711 reports)

Hepatitis treatments and more:

Hepatitis (31,197 reports)

Browse all side effects of Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis:

Hepatitis (1,463 drugs)

Browse all the conditions that are associated with Hepatitis:

Hepatitis (1,522 conditions)

Related publications that referenced our studies

Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Diamox) and Diamox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.